Seller record · Telehealth service

Vitafusions IV

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S4, compounding disclosure: No page states that the compounded semaglutide and tirzepatide are not FDA-approved. The weight loss page and its answers say only that the medications are made in a compounding pharmacy from high quality ingredients. 2 more criteria also fail; see the table below.

At a glance

Vitafusions IVTelehealth service

5/8criteria passed

Price: Compounded semaglutide $149 a month and tirzepatide $189 a month at any dose
Sells: compounded semaglutide, compounded tirzepatide, mobile IV therapy, and 1 more
FDA letters: None on file

Visit Vitafusions IV See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A Dallas-Fort Worth mobile IV therapy company that also runs a telehealth weight loss program for Texas patients, prescribing compounded semaglutide and tirzepatide at one monthly price for every dose after a free consultation and a clinician's telehealth visit. It names its filling pharmacy but prints no street address.

Operating entity Vitafusions IV Texas LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Vitafusions IV's medical weight loss page
S2	Prescription gating	PASS	Vitafusions IV's medical weight loss page; Vitafusions IV's shop page
S3	Pharmacy identification	PASS	Vitafusions IV's medical weight loss page
S4	Compounding disclosure	FAIL	Vitafusions IV's medical weight loss page; Vitafusions IV's website; Vitafusions IV's about page
S5	Analytical documentation	FAIL	Vitafusions IV's medical weight loss page; Vitafusions IV's about page; Vitafusions IV's terms and conditions
S6	Business address	FAIL	Vitafusions IV's contact page; Vitafusions IV's terms and conditions; Vitafusions IV's privacy page
S7	Price disclosure	PASS	Vitafusions IV's medical weight loss page; Vitafusions IV's about page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSEach patient has a telehealth visit with a clinician, who reviews weight loss goals and sets a treatment plan before any medication ships.Source: Vitafusions IV's medical weight loss page.

S2PASSThe weight loss page lists a free consultation booked online as the first step, then a telehealth visit with a clinician who sets the treatment plan, then delivery. No weight loss medication is offered for purchase before that visit.Source: Vitafusions IV's medical weight loss page; Vitafusions IV's shop page.

S3PASSThe answer to where the medication comes from names New Solutions Functional Wellness Pharmacy, with its telephone number, as the pharmacy that mails it.Source: Vitafusions IV's medical weight loss page.

S4FAILNo page states that the compounded semaglutide and tirzepatide are not FDA-approved. The weight loss page and its answers say only that the medications are made in a compounding pharmacy from high quality ingredients.Source: Vitafusions IV's medical weight loss page; Vitafusions IV's website; Vitafusions IV's about page.

S5FAILNo certificate of analysis or lot document is published on the weight loss page, the about page or the terms.Source: Vitafusions IV's medical weight loss page; Vitafusions IV's about page; Vitafusions IV's terms and conditions.

S6FAILNo street address appears on the contact page, in the footer, in the terms or in the privacy policy, which name Vitafusions IV Texas LLC and give only a telephone number and an email address.Source: Vitafusions IV's contact page; Vitafusions IV's terms and conditions; Vitafusions IV's privacy page.

S7PASSCompounded semaglutide costs $149 a month and compounded tirzepatide $189 a month at any dose, with no membership, monthly contract or automatic billing, and the first consultation is free.Source: Vitafusions IV's medical weight loss page; Vitafusions IV's about page.

S8PASSNo FDA warning letter names Vitafusions IV or Vitafusions IV Texas LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, mobile IV therapy, NAD+ IV therapy.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells NAD+

Visit Vitafusions IV

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.